Collegium Pharmaceutical
COLL
COLL
145 hedge funds and large institutions have $476M invested in Collegium Pharmaceutical in 2019 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 36 increasing their positions, 43 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
16% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 43
18% less capital invested
Capital invested by funds: $580M → $476M (-$104M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
145
Holding in Top 10
1
Calls
$395K
Puts
$197K
Top Buyers
| 1 | +$5.98M | |
| 2 | +$3.92M | |
| 3 | +$3.87M | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.07M |
| 5 |
D.E. Shaw & Co
New York
|
+$2.07M |
Top Sellers
| 1 | -$18.7M | |
| 2 | -$12.6M | |
| 3 | -$7.9M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$7.37M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$5.26M |